Drug Profile
Research programme: auto-inducer 2 inhibitors - BioLineRx
Alternative Names: BL-6030; BL-6031; EDP-05Latest Information Update: 26 Mar 2013
Price :
$50
*
At a glance
- Originator Hebrew University of Jerusalem
- Developer BioLineRx
- Class Small molecules
- Mechanism of Action Autoinducer 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 01 Mar 2013 Discontinued - Preclinical for Bacterial infections in Israel (unspecified route)